Influence of Respiratory Gases Conditioning on Aerosol Delivery During Invasive Ventilation (Aerovent-)
Primary Purpose
Brain Injuries, Traumatic
Status
Completed
Phase
Not Applicable
Locations
Belgium
Study Type
Interventional
Intervention
Aerogen Solo®
Heated-humidified circuit
Heated-humidified circuit
Dry ventilator circuit specific for aerosol therapy
Conventional dry ventilator circuit with HME filter
Sponsored by
About this trial
This is an interventional supportive care trial for Brain Injuries, Traumatic
Eligibility Criteria
Inclusion Criteria:
- Aged 18 years or older
- Postoperative neurosurgery intubated patients admitted for brain neurosurgery in the ICU (Intensive care neuro-traumatologic and Toxicologic)- With a healthy lung function.
- Signed and dated informed consent should be obtained in accordance of local regulations.
Exclusion Criteria:
- Spine neurosurgery
- History of cardiovascular and pulmonary disease
- Extubation immediately after surgery
- Modification of the allocated humidification technique before or during the nebulization (heated-humidifier deficiency or safety concern)
- Inaccurate quantification of aerosol deposition (i.e., artifacts or overlap of tracheal and pulmonary deposition).
Sites / Locations
- Cliniques Universiataires Saint-Luc
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm Type
Active Comparator
Active Comparator
Active Comparator
Active Comparator
Arm Label
Heated-humidifier left on during nebulization
Heated-humidifier turned off 30 minutes before nebulization
Use of a heat and moisture exchanger (HME) filter
Use of a dry ventilator circuit specific for aerosol therapy
Arm Description
Outcomes
Primary Outcome Measures
Quantity of aerosol deposition from the nebulizer reservoir to the subject. Measured by Planar scintigraphy.
% of the nominal dose.
Secondary Outcome Measures
Full Information
NCT ID
NCT03464175
First Posted
March 4, 2018
Last Updated
November 2, 2022
Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
1. Study Identification
Unique Protocol Identification Number
NCT03464175
Brief Title
Influence of Respiratory Gases Conditioning on Aerosol Delivery During Invasive Ventilation
Acronym
Aerovent-
Official Title
Influence of Respiratory Gases Conditioning on Aerosol Delivery During Invasive Ventilation: a Randomized Comparative Scintigraphic Study
Study Type
Interventional
2. Study Status
Record Verification Date
November 2022
Overall Recruitment Status
Completed
Study Start Date
January 22, 2018 (Actual)
Primary Completion Date
December 15, 2020 (Actual)
Study Completion Date
December 15, 2020 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The intention is to enroll a specific sample of intubated patients. To compare the effect of respiratory gas conditioning on lung deposition and considering the well-known influences of lung pathology on lung deposition, intubated patients with healthy lungs will be included. Postoperative neurosurgery ventilated patients respond perfectly to this criteria. A previous study including 17 postoperative neurosurgery patients was performed in 2013 with a perfect collaboration between the ICU and the Department of Neurosurgery and Anesthesiology.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Brain Injuries, Traumatic
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
34 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Heated-humidifier left on during nebulization
Arm Type
Active Comparator
Arm Title
Heated-humidifier turned off 30 minutes before nebulization
Arm Type
Active Comparator
Arm Title
Use of a heat and moisture exchanger (HME) filter
Arm Type
Active Comparator
Arm Title
Use of a dry ventilator circuit specific for aerosol therapy
Arm Type
Active Comparator
Intervention Type
Device
Intervention Name(s)
Aerogen Solo®
Intervention Description
Aerosol particles are generated by a vibrating-mesh nebulizer specifically designed for mechanical ventilation
Intervention Type
Device
Intervention Name(s)
Heated-humidified circuit
Intervention Description
It will be left on during the transfer and the nebulization in group 1
Intervention Type
Device
Intervention Name(s)
Heated-humidified circuit
Intervention Description
It will be turned off 30 minutes before the nebulization (nebulization ended max 45 minutes after turning off the heated-humidifier).
Intervention Type
Device
Intervention Name(s)
Dry ventilator circuit specific for aerosol therapy
Intervention Description
Streamlined components, specific position for the nebulizer at 30 cm of a V-shaped Y piece
Intervention Type
Device
Intervention Name(s)
Conventional dry ventilator circuit with HME filter
Intervention Description
The nebulizer is placed between the filter and the endotracheal tube.
Primary Outcome Measure Information:
Title
Quantity of aerosol deposition from the nebulizer reservoir to the subject. Measured by Planar scintigraphy.
Description
% of the nominal dose.
Time Frame
45 minutes
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Aged 18 years or older
Postoperative neurosurgery intubated patients admitted for brain neurosurgery in the ICU (Intensive care neuro-traumatologic and Toxicologic)- With a healthy lung function.
Signed and dated informed consent should be obtained in accordance of local regulations.
Exclusion Criteria:
Spine neurosurgery
History of cardiovascular and pulmonary disease
Extubation immediately after surgery
Modification of the allocated humidification technique before or during the nebulization (heated-humidifier deficiency or safety concern)
Inaccurate quantification of aerosol deposition (i.e., artifacts or overlap of tracheal and pulmonary deposition).
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Pierre-François Laterre, MD, PhD
Organizational Affiliation
Cliniques universitaires Saint-Luc
Official's Role
Principal Investigator
Facility Information:
Facility Name
Cliniques Universiataires Saint-Luc
City
Bruxelles
ZIP/Postal Code
1200
Country
Belgium
12. IPD Sharing Statement
Learn more about this trial
Influence of Respiratory Gases Conditioning on Aerosol Delivery During Invasive Ventilation
We'll reach out to this number within 24 hrs